Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Clinical trial NCT06111638 · RECRUITING
Trial details
- NCT number
- NCT06111638
- Sponsor
- Shanghai Xinzhi BioMed Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2027-05-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.